We are live on
!
Find out more
LI
LMCG Investments Portfolio holdings
AUM
$1.87B
1-Year Est. Return
50.61%
This Fund
S&P 500
This Quarter
Est. Return
+12.85%
1 Year Est. Return
+50.61%
3 Year Est. Return
+124.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.6B
AUM Growth
+$88.6M
(+5.9%)
Cap. Flow
-$48.8M
Cap. Flow
% of AUM
-3.06%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
232
New
4
Increased
49
Reduced
146
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.7M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$9.66M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.58M |
| 4 |
Workday
WDAY
|
+$5.89M |
| 5 |
iShare MSCI Eurozone ETF
EZU
|
+$3.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$13.2M |
| 2 |
Northrop Grumman
NOC
|
+$9.09M |
| 3 |
Zimmer Biomet
ZBH
|
+$6.93M |
| 4 |
Newmont
NEM
|
+$5.77M |
| 5 |
Enphase Energy
ENPH
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Financials | 15.03% |
| 3 | Healthcare | 10.3% |
| 4 | Industrials | 8.69% |
| 5 | Consumer Discretionary | 7.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
151
Marsh
MRSH
$91.5B
| $1.33M | 0.08% |
6,100
-656
| -10% | -$148K |
|
|
152
UnitedHealth
UNH
$370B
| $1.33M | 0.08% |
4,267
-34,441
| -89% | -$13.2M |
|
153
Wells Fargo
WFC
$264B
| $1.26M | 0.08% |
15,737
-690
| -4% | -$49.8K |
|
|
154
Northrop Grumman
NOC
$81.2B
| $1.24M | 0.08% |
2,490
-18,486
| -88% | -$9.09M |
|
155
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$310M
| $1.22M | 0.08% |
77,735
+18,924
| +32% | +$294K |
|
156
Thermo Fisher Scientific
TMO
$220B
| $1.17M | 0.07% |
2,879
-2,762
| -49% | -$1.15M |
|
157
Qualcomm
QCOM
$176B
| $1.12M | 0.07% |
7,010
-16
| -0.2% | -$2.36K |
|
158
iShares Russell 2000 Value ETF
IWN
$14.6B
| $1.08M | 0.07% |
6,834
-83
| -1% | -$12.4K |
|
159
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
| $1.08M | 0.07% |
7,773
-7
| -0.1% | -$886 |
|
160
McDonald's
MCD
$195B
| $1.07M | 0.07% |
3,663
-30
| -0.8% | -$9.25K |
|
161
iShares MSCI Switzerland ETF
EWL
$2.23B
| $1.04M | 0.07% |
19,065
-1,090
| -5% | -$58.2K |
|
162
iShares Core S&P 500 ETF
IVV
$902B
| $1.03M | 0.06% |
+1,652
| New | +$949K |
|
163
RTX Corp
RTX
$301B
| $1.01M | 0.06% |
6,902
-164
| -2% | -$21.9K |
|
164
Analog Devices
ADI
$190B
| $1,000K | 0.06% |
4,201
-21
| -0.5% | -$4.37K |
|
165
iShares MSCI United Kingdom ETF
EWU
$4.16B
| $990K | 0.06% |
24,915
-1,028
| -4% | -$39.5K |
|
166
GE Aerospace
GE
$384B
| $986K | 0.06% |
3,832
-155
| -4% | -$34K |
|
167
CME Group
CME
$94.8B
| $982K | 0.06% |
3,563
| – | – |
|
168
Ecolab
ECL
$79.9B
| $957K | 0.06% |
3,551
-76
| -2% | -$19.3K |
|
169
Willis Towers Watson
WTW
$32B
| $880K | 0.06% |
2,871
-429
| -13% | -$133K |
|
170
Texas Instruments
TXN
$261B
| $878K | 0.06% |
4,228
+100
| +2% | +$17.8K |
|
171
Stryker
SYK
$130B
| $859K | 0.05% |
2,170
-3
| -0.1% | -$1.12K |
|
172
iShares Expanded Tech-Software Sector ETF
IGV
$14.5B
| $852K | 0.05% |
7,782
-583
| -7% | -$57.7K |
|
173
International Paper
IP
$22B
| $795K | 0.05% |
16,975
-406
| -2% | -$19.2K |
|
174
iShares MSCI EAFE Growth ETF
EFG
$17.3B
| $778K | 0.05% |
6,944
-883
| -11% | -$93.1K |
|
|
IPG
175
DELISTED
Interpublic Group of Companies
IPG
| $771K | 0.05% |
31,478
-10,281
| -25% | -$250K |
|
Similar funds
LPU
P3I
BCIM
EPW
EAM
PCP
ACM
WRBC
LMCG Investments's Q2 2025 Portfolio in Review
As of Q2 2025, LMCG Investments held 232 positions worth $1.6B, up 5.9% from $1.51B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
LMCG Investments withdrew a net $48.8M in Q2 2025, closing 7 positions and reducing 146 holdings. Its most notable exit was Zimmer Biomet, an estimated $6.93M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, LMCG Investments opened a new position in iShares Core S&P 500 ETF worth $1.03M.
- LMCG Investments's largest Q2 2025 buy was iShares Core S&P 500 ETF: 1,652 shares worth $1.03M.
- LMCG Investments added most to Regeneron Pharmaceuticals in Q2 2025, an estimated $10.7M increase.
- LMCG Investments's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $13.2M.
- LMCG Investments fully exited Zimmer Biomet in Q2 2025, selling an estimated $6.93M.
- LMCG Investments's ten largest holdings make up 28% of its $1.6B portfolio in Q2 2025.
- LMCG Investments opened 4 new positions and closed 7 in Q2 2025.
- LMCG Investments's portfolio value rose 5.9% quarter-over-quarter to $1.6B.
Based on LMCG Investments's 13F filing for Q2 2025, filed 24 Jul 2025.